Repaglinide M1-D5
| Product Name | Repaglinide M1-D5 |
|---|---|
| Alternate Names | Repaglinide Stable Isotopes, Stable Isotopes of Repaglinide |
| CAT No. | CS-BU-00070 |
| CAS No. | 637301-29-2 (unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 389.50 g/mol |
| Mol. For. | C22H23D5N2O4 |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Repaglinide |
| Smileys | O=C(CC1=CC(OC([2H])([2H])C([2H])([2H])[2H])=C(C(O)=O)C=C1)N[C@H](C(C=CC=C2)=C2N)CC(C)C |
| Canonical Smiles | CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N)C(=O)O |
| InchIKey | OSCVKZCOJUTUFD-IBGZPJMESA-N |
| Inchl | InChI=1S/C22H28N2O4/c1-4-28-20-12-15(9-10-17(20)22(26)27)13-21(25)24-19(11-14(2)3)16-7-5-6-8-18(16)23/h5-10,12,14,19H,4,11,13,23H2,1-3H3,(H,24,25)(H,26,27)/t19-/m0/s1 |
| IUPAC | 4-[2-[[(1S)-1-(2-aminophenyl)-3-methylbutyl]amino]-2-oxoethyl]-2-ethoxybenzoic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Repaglinide M1-D5 is a metabolite of Repaglinide, a medication used to treat type 2 diabetes. This metabolite is formed when Repaglinide is metabolized by the liver. Repaglinide M1-D5 is an active metabolite and has similar pharmacological effects as Repaglinide.
The primary mechanism of action of Repaglinide M1-D5 is to stimulate insulin release from the pancreas. This leads to a decrease in blood glucose levels. Repaglinide M1-D5 is a fast-acting medication and is usually taken just before a meal. It is recommended to take this medication with the first bite of a meal to achieve optimal results.
The chemical structure of Repaglinide M1-D5 is similar to Repaglinide. Both medications belong to the class of drugs known as meglitinides. Repaglinide M1-D5 has a molecular weight of 426.57 g/mol and a chemical formula of C24H28N2O4S.
Repaglinide M1-D5 is primarily eliminated from the body through the kidneys. Patients with impaired renal function may require a lower dosage of Repaglinide M1-D5 to avoid adverse effects. Common side effects of this medication include hypoglycemia, weight gain, and gastrointestinal disturbances.
In conclusion, Repaglinide M1-D5 is an active metabolite of Repaglinide used to treat type 2 diabetes. It works by stimulating insulin release from the pancreas and has a fast onset of action. It is primarily eliminated through the kidneys and may cause side effects such as hypoglycemia and weight gain.
Get an Instant Quote
Related Compounds
Repaglinide D5 | Repaglinide M2-D5 |